Association-based predictions of pathogen characteristics

Details Association-based predictions of pathogen characteristics Association-based predictions of pathogen characteristics

2011-08-16

2011-08-16

Clow, Lori A (Department: 1631)

Data processing: measuring, calibrating, or testing

Measurement system in a specific environment

Biological or biochemical

C702S020000, C702S030000

Reexamination Certificate

active

08000900

ABSTRACT:
A system comprising a machine learning classifier trained on a plurality of associations between a host and a pathogen to predict a pathogen characteristic is described herein. The pathogen characteristic can relate to a disease state of the host. Computer-executable instructions for performing a method of forecasting a portion of a target molecule anticipated to influence an organism's condition also are described herein. The method comprises employing population data to automatically analyze one or more areas of the target molecule to determine the portion of the target molecule anticipated to influence the organism's condition. The population data can pertain to at least one relationship between at least one diverse organism trait and the target molecule. One or more epitopes forecast by employing the method also are contemplated.

REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3839153 (1974-10-01), Schuurs et al.
patent: 4051728 (1977-10-01), Metz
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4342566 (1982-08-01), Theofilopolous et al.
patent: 4493795 (1985-01-01), Nestor, Jr. et al.
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4900811 (1990-02-01), Sutcliffe
patent: 5019369 (1991-05-01), Presant et al.
patent: 5426039 (1995-06-01), Wallace et al.
patent: 5698767 (1997-12-01), Wilson et al.
patent: 5709843 (1998-01-01), Reisner
patent: 2002/0182222 (2002-12-01), Groot
patent: 2004/0072249 (2004-04-01), Hoffman et al.
“Q&A. Microsoft Researchers Use Machine Learning Techniques to Help Advance HIV Vaccine Research” http://www.microsoft.com/presspass/features/2005/feb05/02-23HIVResearch mspx 5 pgs Last Accessed: Sep. 15, 2006.
“Microsoft Research Collaborates With HIV Researchers to Create Advanced Vaccine Models Fact Sheet” http://www.microsoft.com/presspass/press/2005/feb05/0223HIVVaccineFS mspx 3 pgs Last Accessed: Sep. 15, 2006.
“Microsoft Scientists Search for Breakthroughs in HIV Vaccine Design” http://www.microsoft.com/presspass/press/2005/feb05/02-23HIVVaccinePR.mspx. 3 pgs. Last Accessed: Sep. 15, 2006.
Moore et al. “Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level.” Science, vol. 296, Issue 5572, pp. 1439-1443, May 24, 2002.
McKinney et al. “Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced OTL1.” The Journal of Immunology, 2004, pp. 1941-1950, vol. 173.
“CTLPred: A SVM & ANN Based CTL epitope Prediction method” http://www.imtech.res.in/raghava/ctlpred/about html 7 pgs Last Accessed: Sep. 15, 2006.
“HIV Databases” http://www.hiv.lanl.gov/content/index. Last Accessed: Feb. 13, 2007. 2 pgs.
“SYFPEITHI” http://www.SYFPEITHI.de Last Accessed Sep. 15, 2006 1 pg.
Kohavi. “A study of cross-validation and bootstrap for accuracy estimation and model selection.” In Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, pp. 1137-1143. San Mateo, CA: Morgan Kaufmann, 1995 7 pgs.
Allen, et al., “Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection.” Journal of Virology, Jul. 2004, pp. 7069-7078, vol. 78, No. 13, 10 pgs.
Leslie, et al., “Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.” JEM, Mar. 21, 2005 pp. 891-902, vol. 201, No. 6 12 pgs.
Leslie et al., “HIV evolution CTL escape mutation and reversion after transmission.” Nat Med 10(3):282-289. 2004 25 pgs.
Parker et al. “Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.” Journal of Immunology. 1994. 152:163-75, 13 pgs.
Jojic et al. “Using ‘epitomes’ to model genetic diversity Rational design of HIV vaccine cocktails.” Presented at The Conference on Neural Information Processing Systems on Dec. 7, 2005, 7 pgs.
Bhasin et al. “MHCBN: A comprehensive database of MHC binding and non binding peptides.” Bioinformatics (2003) vol. 19, 665-666, 2 pgs.
Rammensee et al. “SYFPEITHI: database for MHC ligands and peptide motifs,” Immunogenetics (1999) 50:213-219, 7 pgs.
Nolan et al. “Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battle ground.” AIDS. vol. 18(9). Jun. 18, 2004. pp. 1231-1240. 14 pgs.
Feeney et al. “HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.” Journal of Immunology. Jun. 15, 2005: 174(12) pp. 7524-7529, 7 pgs.
Mallal. “HIV adaptation to genetic polymorphisms of the host.” 10th Conference on Retroviruses and Opportunistic Infections. Boston, MA, Feb. 10-14, 2003, 1 pg.
Mallal et al. “HIV adaptation to HLA-restricted immune responses—implications for vaccine design and evaluation.” 10th Conference on Retroviruses and Opportunistic Infection, Boston, MA, Feb. 10-14, 2003, Abstract No. C-27 (327), 1 pg.
Allen et al. “Sterotypic escape from CDB+ T cell responses represents a major driving force of HIV-1 sequence diversity and reveals constraints on HIV-1 evolution” 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, Feb. 22-25, 2005, Abstract No. 463, 1 pg.
Park et al. “HLA-restricted immune responses have driven the evolution of HIV-1 clades.” 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA, Feb. 22-25, 2005, 2 pgs.
Jojic et al., HLA-driven optimization of an HIV vaccine immunogen. 12th Conference on Retroviruses and Opportunistic Infections, Boston USA, Feb. 22-25, 2005, Session 89 Poster Abstracts 2 pgs.
“Q&A: Microsoft Researchers Use Machine Learning Techniques to Help Advance HIV Vaccine Research.” http://www.microsoft.com/presspass/features/2005/feb05/02-23HIVResearch.mspx. Last accessed on Feb. 13, 2007, 5 pgs.
“Microsoft Research Collaborates With HIV Researchers to Create Advanced Vaccines Models Fact Sheet.” http://www.microsoft.com/presspass/press/2005/feb05/0223HIVVaccineFS.mspx. Last accessed on Sep. 25, 2006, 3 pgs.
Bhasin et al. “Prediction of CTL epitopes using QM, SVM and ANN techniques.” http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Display&DB=pubmed. Last accessed on Sep. 25, 2006, 2 pgs.
Jin et al. “Identification of Subdominant Cytotoxic T Lymphocyte Epitopes Encoded by Autologous HIV Type 1 Sequences, Using Dendritic Cell Stimulation and Computer-Driven Algorithm.” Aids Research and Human Retroviruses. vol. 16, No. 1, 2000. pp. 67-76, 10 pgs.
Bird et al. “HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades.” AIDS, 2002, vol. 16, pp. 1899-1904 6 pgs.
Fang et al “Analysis of Transition from Long-Term Nonprogressive to Progressive Infection Identifies Sequences that May Altenuate HIV Type 1.” Aids Research And Human Retroviruses. vol. 17, No. 15, 2001, pp. 1395-1404, 10 pgs.
Yuste et al. “Unusual Distribution of Mutations Associated with Serial Bottieneck Passages of Human Immunodeficiency Virus Type 1.” Journal of Virology. vol. 74, No. 20. Oct. 2000, p. 9546-9552 7 pgs.
Anderson et al. “Nel from Primary Isolates of Human Immunodeficiency Virus Type 1 Suppresses Surface CD4 Expression in Human and Mouse T Cells.” Journal of Virology, Aug. 1993, vol. 67, No. 8, p. 4923-4931 9 pgs.
Gunthard et al. “Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy.” Journal of Virology. Mar. 1998, p. 2422-2428, vol. 72, No. 3, 7 pgs.
Desire et al. “Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR Assay.” Journal of Clinical Microbiol

Affiliated with

Also associated with

Rating

Association-based predictions of pathogen characteristics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Association-based predictions of pathogen characteristics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Association-based predictions of pathogen characteristics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2746739